Pharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage IVA-B Head and Neck Cancer
Conditions:   Larynx;   Lip, Oral Cavity and Pharynx Interventions:   Biological: Nivolumab;   Biological: Ipilimumab;   Radiation: Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy;   Radiation: Volume Modulated Arc Therapy Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Bristol-Myers Squibb Recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2017 Category: Research Source Type: clinical trials